Q1 2024 STRATA Skin Sciences Inc Earnings Call Transcript
Key Points
- Strata Skin Sciences Inc (SSKN) has successfully expanded its DTC marketing, leading to over 500 patient appointments at a cost-effective rate, demonstrating effective patient acquisition strategies.
- The company has strategically optimized its device placements, removing underperforming devices and reallocating them to higher potential clinics, which is expected to enhance device utilization and revenue.
- Strata Skin Sciences Inc (SSKN) reported a smaller decline in gross domestic recurring billings compared to previous quarters, indicating potential stabilization and improvement in domestic revenue streams.
- The company has continued to grow its installed base of therapy Rx devices, with an increase from 92 devices at the end of 2023 to 104 devices by March 31, 2024, showing progress in market penetration.
- Strata Skin Sciences Inc (SSKN) has extended its exclusive distribution agreements in key international markets such as Korea, China, and Japan, which is expected to support sustained revenue contributions from these regions.
- Total revenue for the first quarter of 2024 decreased to $6.8 million from $7.6 million in the same quarter the previous year, indicating a drop in overall earnings.
- Gross profit margin declined to 45.6% in the first quarter of 2024 from 58% in the corresponding period in 2023, primarily due to higher depreciation costs and material costs.
- The company experienced a decrease in equipment revenue in the first quarter of 2024 compared to the same period in 2023, reflecting challenges in equipment sales.
- Strata Skin Sciences Inc (SSKN) reported a write-off of obsolete inventory assets, which could indicate issues with inventory management or product demand.
- Despite strategic initiatives, the company still faces challenges in achieving profitability and positive cash flow, as indicated by the ongoing need to optimize device placements and control costs.
Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to the STRATA Skin Sciences Inc. first quarter of 2024 financial results and corporate update conference call. (Operator Instructions)
Participants of this call are advised that the audio of this conference call is being broadcast live over the Internet and is also being recorded for playback purposes. A webcast replay of the call will be available approximately one hour after the end of the call through November 15, 2024.
And with that, I'd like to turn the call over to [Joey Delahoussaye].
Please go ahead.
Good afternoon, and thank you for participating in today's conference call. Earlier this afternoon, the company released its financial results for the quarter ended March 31, 2024. A copy of that press release can be found on the company's website at www.strataskinsciences.com under the Investors tab.
Joining me on today's earnings call
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
